Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 1;57(2):157-64.
doi: 10.1097/QAI.0b013e318214ba4a.

Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe

Charles S Morrison  1 , Pai-Lien Chen, Immaculate Nankya, Anne Rinaldi, Barbara Van Der Pol, Yun-Rong Ma, Tsungai Chipato, Roy Mugerwa, Megan Dunbar, Eric Arts, Robert A Salata
Affiliations

Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe

Charles S Morrison et al. J Acquir Immune Defic Syndr. .

Abstract

Background: HIV-infected women need highly effective contraception to reduce unintended pregnancies and mother-to-child HIV transmission. Previous studies report conflicting results regarding the effect of hormonal contraception on HIV disease progression.

Methods: HIV-infected women in Uganda and Zimbabwe were recruited immediately after seroconversion; CD4 testing and clinical examinations were conducted quarterly. The study end point was time to AIDS (two successive CD4 200 cells/mm or less or World Health Organization advanced Stage 3 or Stage 4 disease). We used marginal structural Cox survival models to estimate the effect of cumulative exposure to depot-medroxyprogesterone acetate and oral contraceptives on time to AIDS.

Results: Three hundred three HIV-infected women contributed 1408 person-years. One hundred eleven women (37%) developed AIDS. Cumulative probability of AIDS was 50% at 7 years and did not vary by country. AIDS incidence was 6.6, 9.3, and 8.8 per 100 person-years for depot-medroxyprogesterone acetate, oral contraceptive, and nonhormonal users. Neither depot-medroxyprogesterone acetate (adjusted hazard ratio, 0.90; 95% confidence interval, 0.76-1.08) nor oral contraceptives ( adjusted hazard ratio, 1.07; 95% confidence interval, 0.89-1.29) were associated with HIV disease progression. Alternative exposure definitions of hormonal contraception use during the year before AIDS or at the time of HIV infection produced similar results. Sexually transmitted infection symptoms were associated with faster progression, whereas young age at HIV infection (18-24 years) was associated with slower progression. Adding baseline CD4 level and set point viral load to models did not change the hormonal contraception results, but Subtype D infection became associated with disease progression.

Conclusion: Hormonal contraceptive use was not associated with more rapid HIV disease progression, but older age, sexually transmitted infection symptoms, and Subtype D infection were.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: Barbara Van Der Pol consults for Roche Diagnostics. We declare no other conflicts of interest.

References

    1. AIDS epidemic update, November 2009. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2009.
    1. Hoffman IF, Martinson FE, Powers KA, et al. The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr. 2008;47(4):477–483. - PubMed
    1. Desgrees-Du-Lou A, Msellati P, Viho I, et al. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. Int J STD AIDS. 2002;13(7):462–468. - PubMed
    1. United Nations Family Planning Association (UNFPA) UNFPA annual report 2000. New York: United Nations Population Fund; 2001.
    1. World Health Organization (WHO), United Nations Family Planning Association (UNFPA) Glion consultation on strenghtening the linkages between reproductive health and HIV/AIDS: family planning and HIV/AIDS in women and children. Geneva: WHO; 2006.

Publication types

Substances